. 2021 May 24;44:102014. doi: 10.1016/j.redox.2021.102014

Table 1.

Vimentin modification sites identified in SIN-1 treated and untreated cardiac cells. * Indicates modifications via Schiff base formation.

AA	#_modified	#_{modifications}	modified residues	modifications
Arg	1	1	R158^d	^dGlutamic semialdehyde
Cys	1	7	C328^bcefghi	^bDioxidation, ^cTrioxidation, ^eGlutathionylation, ^fGlyoxal, ^gHexenal, ^hNitrosation, ⁱPentenal
His	5	3	H238^g, H253^g, H437^gj, H461^ag, H462^ag	^aOxidation, ^gHexenal, ^jHNE
Lys	20	12	K97^gjm, K104^m, K120^m, K129^gkmnors, K139^gmq, K143^glm, K188^gm, K223^gkmq, K235^gjmq, K236^glmq, K262^g, K282^gm, K292^gm, K294^gm, K313^m, K334^p, K373^gim, K402^gm, K439^gm, K445^gjlm	^kAcetylation, ^lDimethylation, ^mFormylation, ⁿGlyoxal, ^gHexenal, ^oHHE, ^jHNE, ^pMethylation, ^qMethylglyoxal/MDA, ⁱPentenal, ^rOxo-pentanal*, ^sSuccinylation
Met	10	2	M14^a, M74^a, M154^ab, M183^ab, M193^a, M344^ab, M347^ab, M372^ab, M376^ab, M391^a	^aOxidation, ^bDioxidation
Phe	2	1	F295^a, F351^a	^aOxidation
Pro	1	3	P57^abt	^aOxidation, ^bDioxidation, ^tPyroglutamic acid
Ser	10	1	S25^u, S39^u, S49^u, S56^u, S66^u, S83^u, S144^u, S226^u, S430^u, S459^u	^uPhosphorylation
Thr	4	2	T37^u, T327^v, T426^v, T458^uv	^v2-amino-3-ketobutyric acid, ^uPhosphorylation
Trp	1	6	W290^abcwxy	^aOxidation, ^bDioxidation, ^cTrioxidation, ^wHydroxykynurenine, ^xKynurenine, ^yOxolactone
Tyr	6	5	Y38^auz, Y53^abz, Y61^abz+, Y150^a, Y291^abz, Y400^a	^aOxidation, ^bDioxidation, ^zDopaquinone, ⁺Nitration, ^uPhosphorylation